The Objectives of This Study Are Study the Safety, Reactogenicity and Obtain Preliminary Data on the Immunogenicity of Flu-M Quadro, 4-valent Inactivated Split Influenza Vaccine, in Healthy Volunteers

NCT05152017 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

75

Enrollment

OTHER_GOV

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Flu-M Quadro [inactivated split influenza vaccine] with preservative
BIOLOGICAL: Flu-M Quadro [inactivated split influenza vaccine] without preservative
BIOLOGICAL: Placebo

Sponsor

St. Petersburg Research Institute of Vaccines and Sera